Neck bypass surgery aimed at flushing out Alzheimer's toxins begins human testing

NCT ID NCT06965062

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early study tests a surgical procedure that reroutes lymphatic vessels in the neck to help the brain drain waste proteins linked to Alzheimer's. Ten people with mild-to-moderate Alzheimer's will undergo the operation and be followed for two years. The main goals are to check safety and see if there are any signs of cognitive improvement.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Deep cervical lymph node to venous bypass surgery (a procedure to reroute lymphatic drainage from the neck to a vein)
What this could lead to
If it works, this could point toward a new surgical approach to slow or improve cognitive decline in Alzheimer's by helping the brain clear toxic proteins.
What could go wrong
This is a very small, early proof-of-concept study with only 10 participants. Surgery carries risks like infection, nerve injury, or anaesthetic complications. The approach is highly experimental and may not show meaningful benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Changi General Hospital

    RECRUITING

    Singapore, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.